Royalty Report: Medical, Device, Surgical – Collection: 118680

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 20

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 20

Primary Industries

  • Medical
  • Device
  • Surgical
  • Ophthalmological
  • Scientific & Technical Instruments
  • Therapeutic
  • Laser
  • cardiac
  • Disposable
  • Eye Surgery Procedure
  • Electro Medical/ Elector therapeutic
  • Skin care
  • Supply

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 240566

License Grant
Licensor, an individual, hereby grants to Licensee a sole and exclusive, worldwide license under the Patent Rights to make, use, offer for sale and sell the Licensed Products in the Field of Use. Licensee shall have the right to sub-license its rights hereunder to no more than one sub-licensee in each country in the world (reserving no rights to itself in the territory of any such sub-license) on prior written notice (which shall include the name of the sub-licensee and the territorial scope of its sub-license) to Licensor. Each such sub-license shall be subject and subordinate to the terms and conditions of this Agreement, except that no sub-licensee shall have the right to grant further sub-licenses.
License Property
Patent Rights shall mean U.S. Patent Nos. 5,549,632 and 5,984,916
5,549,632 – Method and apparatus for ophthalmic surgery
5,984,916 – Ophthalmic surgical laser and method
Field of Use
Field of Use shall mean use for ophthalmic surgery.

IPSCIO Record ID: 233464

License Grant
Licensor grants a non-exclusive, worldwide license, without the right to sublicense, to make, have made, use, import, sell, offer for sale, or otherwise dispose of Licensed Products, and to practice any method or process involved in the manufacture, testing or use thereof, under the Licensed Licensor Patents.
License Property
Licensor is the exclusive licensee of U.S. Patent No. 4,784,135 and  No. 4,686,979.

The Licensed Products means Lasers, and, Disposables.  Laser shall mean any source of amplified, coherent light having a wavelength between 100 and 400 nanometers.  Disposable shall mean apparatus comprised, at least in part, or one of more optical fibers, that is or may be coupled to a Laser, as hereinafter defined, to guide the light emitted from that Laser to a treatment location within a human or animal body. Such apparatus shall fall within the definition of Disposable irrespective of whether it is intended for use in more than one procedure.

Field of Use
This agreement is for the field of transmyocardial revascularization or percutaneous transmyocardial revascularization.

Transmyocardial laser revascularization (TMR) is a procedure used to treat inoperable heart disease in people with persistent angina that isn't relieved by any other revascularization method.

IPSCIO Record ID: 28111

License Grant
The Licensee entered into an Agreement with the Licensor, in October 1998 that grants the Licensee an exclusive License under U.S. Patent No. 5,630,810 relating to a treatment method for preventing the formation of central islands during laser surgery.
License Property
The Licensor owns Patent No. 5,630,810 relating to a treatment method for preventing the formation of central islands during laser surgery. Central islands are a problem generally associated with laser refractive surgery performed with broad beam laser systems used to ablate corneal tissue.
Field of Use
Healthcare Services

IPSCIO Record ID: 158782

License Grant
Pursuant to a prior employment agreement, the Licensor, of Japan and residing in the U.S. and the Licensee have a contractual agreement for patents.
License Property
The patents are for Contact Laser(TM) Probes and Scalpels and Contact Fibers, Heraeus LaserBlade(TM) Scalpels and Contact Fibers, HSI conical contact fibers.

'Contact Laser(TM) Patents' means the following three U.S. Patent Nos. 4,693,244; 4,592,353; and 4,736,743.

Field of Use
Licensee's Contact Laser(TM) System, unlike conventional laser systems, enables the surgeon to use the laser instrument in direct contact with the tissue being treated, thereby significantly enhancing the ease of use and precision of laser surgery in many applications.

IPSCIO Record ID: 5568

License Grant
The licensee obtained an exclusive licensing for cardiovascular uses of proprietary argon gas based technology – a cryoablation system designed to treat cardiac arrhythmias.
License Property
Cryoablation is a process that uses cold energy (cryo) to kill tissue (ablation).

Cryoablation is used in a variety of clinical applications using hollow needles (cryoprobes) through which cooled (from a peripheral freezing unit), thermally conductive, gases and fluids are circulated. Cryoprobes are inserted into or placed adjacent to tissue which is determined to be diseased in such a way that ablation will provide correction yielding benefit to the patient. When the probes are in place, the cryogenic freezing unit removes heat ('cools') from the tip of the probe and by extension from the surrounding tissues.

IPSCIO Record ID: 27310

License Grant
The Company entered into agreements for its laser technology for reshaping human eyes.
License Property
The technology allows physicians to re-contour the cornea to adjust for vision impairments, thus eliminating the need for glasses or contact lenses.

IPSCIO Record ID: 7744

License Grant
Licensor desires to license exclusive manufacturing rights and exclusive marketing rights for this device, including any derivative devices, substantially conforming to the specifications as well as the exclusive right to use its mark EX-308 on devices RA intends to manufacture and market.
License Property
Licensor has received clearances from the US Food and Drug Administration denominated 510K k993328 and k020973, to market a laser device having certain specifications.

EX-308 Excimer Laser is the name applied to any product cleared to market by the FDA under 510k k993328 and k020973 and bearing the mark 'EX-308'.

Field of Use
PHAROS excimer lasers are xenon chloride (XeCl) lasers that deliver concentrated, high-dose monochromatic 308nm UVB phototherapy directly to psoriatic and depigmented lesions limiting exposure to surrounding healthy tissue. Unlike conventional UVB systems that emit wavelengths from 290 to 320nm, PHAROS excimer lasers deliver only monochromatic 308nm, an efficacious wavelength for treating psoriasis, vitiligo, atopic dermatitis, and leukoderma.

IPSCIO Record ID: 1710

License Grant
The Company hereby grants an exclusive, worldwide right and license, including the right to grant sublicenses, under the Technical Know-How, Licensed Patents and Improvements to practice methods and to manufacture, have manufactured, import, use, offer to sell, sell and otherwise dispose of Licensed Products within the Field of Technology; technology applications relating to the use of lasers to treat cardiovascular or vascular disease.
License Property
Licensed Products shall mean Patented Licensed Products and Unpatented Licensed Products and shall include single use, disposable products as well as the related laser hardware.

Transmyocardial laser revascularization (TMLR) has emerged as a promising therapy for patients with end-stage coronary artery disease not amenable to other forms of therapy. TMLR is a surgical technique typically performed through a left thoracotomy, which uses a laser to bore 15 to 30 transmural channels from the epicardial to the endocardial surfaces through the left ventricular myocardium of the beating heart in an attempt to improve local perfusion to ischemic myocardial territories not being reached by diseased arteries.

Field of Use
Field of Technology  shall mean the use of lasers to treat cardiovascular or vascular disease.

IPSCIO Record ID: 203491

License Grant
The University hereby grants to the Licensee a co-exclusive license (with New Star) to the Regents Patent Rights, for the following fields of use (i) for procedures that involve non-ablative laser skin rejuvenation including collagen formation, collagen remodeling, skin smoothing and wrinkle treatment, (ii) for procedures that involve the treatment of facial and lower extremities telangiestasias and spider veins and (iii) for procedures using a long pulse [0.2 – 500 milliseconds] 1.06 UM Nd.YAG laser (collectively, the 'Co-exclusive Fields of Use') and grants to the Licensee an exclusive license to the Regents Patent Rights for the following fields of use for procedures that involve (i) vascular skin lesions and (ii) laser hair removal (collectively, the 'Exclusive Fields of Use'), to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method. The Regents hereby grants to Licensee a non-exclusive license under The Regents Patent Rights to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method in any fields of use not covered by the Co-exclusive Fields of Use and the Exclusive Fields of Use. The Regents specifically retains all rights to grant Further Licenses to The Regents Patent Rights to any party for fields of use not covered by the Co-Exclusive Fields of Use and the Exclusive Fields of Use.

This Agreement grants the exclusive right, co-exclusive right, or nonexclusive right to use or sell the Patent Products in the United States within specified fields of use, Licensee agrees that any Patent Products embodying the Regents Patent Rights or produced through the use thereof will be manufactured substantially in the United States.

License Property
Regents Patent Rights means all U.S. patents and patent applications and foreign patents and patent  applications assigned to The Regents, including any reissues, extensions, substitutions, continuations, divisions and continuations-in-part (only to the extent, however, that claims in any continuations-in-part not listed below are entitled to the priority filing date of any of the below listed patents and patent applications) based on and including any subject matter claimed in or covered in U.S. Patent Application Serial Number 08/222,976 entitled 'Apparatus and Method for Dynamic Cooling of Biological Tissues for Thermal Mediated Surgery' now  abandoned; filed April 5, 1994; and assigned to The Regents. As of the effective date of this Agreement, the Regents Patent Rights include the following patents and patent applications
93-364-2            08/441930                                US    5,814,040 issued 09/29/98
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery
93-364-3            08/870467                                US   5,979,454 issued 11/09/99
Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
93-364-4            08/963531                                US   6,171,301 B1 issued 01/09/01
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery

Patent Products means any kit, composition of matter, material, or product whose manufacture, use, or sale in a particular country would infringe, but for the license granted to Licensee pursuant to this Agreement, an unexpired Claim of a patent or pending claim of a patent application under Regents Patent Rights in that country in which such patent has issued or application is pending; any kit, composition of matter, material, or product to be used in a manner requiring the performance of the Patent Method; or any kit, composition of matter, material, or product produced by the Patent Method. This definition of Patent Products also includes a service either used by Licensee or provided by Licensee to its customers when such service requires the practice of the Patent Method. Dynamic Cooling Device (or DCD) means a cooling device for use with a laser system, the combination of which utilizes the Regents Patent Rights. DCDs, whether sold as (i) an accessory or upgrade product to a laser system or (ii) integrated with a laser system as one product, are Patent Products.

Field of Use
Dynamic Cooling Device (DCD) is a device which cools the top layer of the skin, while leaving the targeted underlying hair follicle, vein or other structure at normal temperature. As a result, higher levels of laser energy can be delivered during treatment, while minimizing thermal injury, pain, and the inconvenience associated with anesthetics. The design of the hand-held DCD enables the practitioner to clearly see the area being treated, and the combined efficiency of the lasers and DCD reduces the risks of over treatment. The DCD delivers the appropriate amount of cooling quickly and consistently.

IPSCIO Record ID: 1814

License Grant
The Company secured the exclusive worldwide right to the laser-based Photon machine from the Licensor, an individual.
License Property
The Photon (trademark) LaserPhaco (trademark) system is protected under a United States patent issued in 1987 (U.S. Patent Number 4,694,828) for the utility and methods of laser ablation, aspiration and irrigation of tissue through a hand-held probe of a unique design.
Field of Use
The rights granted apply to cataracts of the eye; ophthalmic cataract surgery equipment.

IPSCIO Record ID: 714

License Grant
Licensor, an individual, hereby grants to Licensee a world-wide exclusive, nontransferable, personal, sublicenseable only to those companies against which Licensee enforces the Rentrop Patents pursuant to this Agreement, revocable, royalty-bearing license under the Rentrop Patents to make, use, offer for sale, import, sell, or otherwise dispose of Licensed Catheters.
Licensor hereby grants to the Licensee a world-wide exclusive, nontransferable, personal, subLicenseable, as a result of the litigation in the U.S. District Court for the Southern District of New York. The Litigation was tried to the jury, resulting in a jury verdict on December 8, 2006 of infringement of claims 1, 8, and 15-17 of U.S. Patent Nos. 6,673,064. The License granted under this Agreement shall continue in full force and effect from the effective date until January 4, 2020.
License Property
Licensor is the sole inventor of and owns all right, title, and interest in and to U.S. Patent Nos. 6,440,125 and 6,673,064 and any applications claiming priority thereto.

IPSCIO Record ID: 26669

License Grant
A former employee and director of the Company is entitled to revenues from sales of presbyopia products covered by current patents and patents applications he has assigned to the Company.
License Property
Our target market is refractive surgery, particularly for correction of presbyopia, one of the last frontiers of ophthalmology. We believe our new method of laser presbyopia reversal (LAPR) using a laser for surgical correction, is less complicated, more stable, and may provide less regression than mechanical, non-laser methods. We own 16 patents, along with 17 pending patent applications pertaining to presbyopia reversal. We have also submitted two Patent Corporation Treaties for international patents.

IPSCIO Record ID: 1098

License Grant
Licensor grants Licensee a non-exclusive, world-wide license under the Licensed Patents to the Licensed Devices for Licensed Applications which would infringe any valid claim of the Licensed Patents.
License Property
Licensor is the owner of U.S. Patent No. 5,037,421 and U.S. Patent No. 5,147,354 both entitled 'Mid Infrared Laser Arthroscopic Procedure'.

LICENSED DELIVERY DEVICE shall mean any device that delivers the laser energy to a desired location which infringes one or more of the valid claims of the Licensed Patents.

Field of Use
LICENSED APPLICATION shall mean only orthopedic applications.

IPSCIO Record ID: 10297

License Grant
The Company signed a License Agreement with the Licensor for the Licensor's patents for ultraviolet light ophthalmic products/procedures.
License Property
Certain patents relate to Ultraviolet Light Ophthalmic (ULO) products and procedures.

IPSCIO Record ID: 203456

License Grant
Attached to this settlement agreement, the Licensor grants a worldwide non-exclusive license under Licensors Patent Rights and Know-how to make, have made for it, use, and sell Licensed Products. The license granted herein is expressly limited to the specific Licensed Products defined herein, and does not include the right to sublicense except to an Affiliate.

This license granted for Laser Angioplasty Catheters is non-cancelable by Licensee during the period from the Effective Date through June 30, 2009.

This license granted for Non-Laser Functioning Catheters and Guidewires for use with Licensees Laser Therapy Systems is non-exclusive.

License Property
The licensors patents include, but are not limited to, Method of Improving the Biocompatibility of Solid Surfaces, Surface Coating Agents and Substrate Surface Preparation.

The Licensed Products means Medical Products that are surface-treated with photoreactive polyvinylpyrrolidone copolymer, non-photoreactive polyvinylpyrrolidone, photoreactive polyacrylamide copolymer, one or more of the photoreactive crosslinking agents known to the parties as PR01 and PR04, a compound for promoting polymer-to-metal adhesion known to the parties as TL03, or any combination of these compounds, for the purpose of providing a lubricious surface to the Medical Products.

MEDICAL PRODUCTS-B1 Laser Angioplasty Catheters
The Medical Products means excimer laser angioplasty catheters specifically adapted for coronary and peripheral use. Medical Products includes Licensees chronic total occlusion laser angioplasty catheters.

MEDICAL PRODUCTS-B2 Non-Laser Functioning Catheters and Guidewires for use with Spectranetics Laser Therapy Systems
The Medical Products means the following Licensee-labeled non-laser functioning catheters and guidewires for Licensees laser therapy system that are specifically designed and labeled for use solely with laser angioplasty catheters (I) BIAS sheath, (ii) support catheters, (iii) cardiac lead locking device, and (iv) chronic total occlusion steerwires.  Medical Products does not include catheters for (I) infusion of diagnostic, therapeutic, or embolic agents in the neurovascular region, or (ii) insertion of therapeutic embolic devices in the neurovascular region. Medical Products does not include catheters used to deliver stents of any type.

Field of Use
Licensee designs, manufactures, markets and distributes single-use medical devices used in minimally invasive surgical procedures within the vascular system in conjunction with our proprietary excimer laser system.

IPSCIO Record ID: 7652

License Grant
The Licensor granted the undisclosed Licensee the use of the laser patents.
License Property
The Licensor technology involves ophthalmic lasers which may be used in the laser eye-surgery market.

IPSCIO Record ID: 476

License Grant
Licensor hereby grants an exclusive a royalty-bearing license, with the right to grant sublicenses under the Reliant Intellectual Property solely to make, have made, use, import, offer for sale and sell Products in the Field on a worldwide basis.
License Property
The technology involved includes CO2 laser accessories and scanners primarily for use in cosmetic and surgical applications.  U.S. Patent No. 5995265, 5786924, 5546214, 5420882, 5128509 and 5163936.
Field of Use
Field means use in surgical (including cosmetic and/or aesthetic) applications or veterinary applications.

IPSCIO Record ID: 27345

License Grant
The Company has been granted three United States patents relating to the use of tissue on a removable backing which cover the sleeve configuration of Peri- Strips, the combination of tissue with a surgical stapling gun, and methods of performing a surgical procedure to remove diseased tissue.
License Property
Patent relates to Peri-Strips Dry covering the application of buttressing material (tissue or other synthetic material) onto a surgical stapler for purposes of reinforcing a surgical fastener suture line utilizing an adhesive substance and a positional and pressure equalization device to accomplish the adherence of the tissue to the surgical suturing device.

IPSCIO Record ID: 27502

License Grant
The Company has been granted nonexclusive rights under United States and foreign patents that include claims that cover ultraviolet laser technology for removal of human tissue.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.